Market Cap 2.31B
Revenue (ttm) 1.17B
Net Income (ttm) -167.10M
EPS (ttm) N/A
PE Ratio 15.48
Forward PE 13.09
Profit Margin -14.31%
Debt to Equity Ratio 39.10
Volume 372,900
Avg Vol 325,000
Day's Range N/A - N/A
Shares Out 35.29M
Stochastic %K 12%
Beta 1.31
Analysts Strong Sell
Price Target $79.25

Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 843 740 2300
Address:
4920 O'Hear Avenue, Suite 400, North Charleston, United States
IN0V8
IN0V8 Mar. 3 at 6:19 PM
$NGVT 3/2 Buy BMO raises target price to $83 from $70
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 6:11 PM
$NGVT just threw up a red flag ⚠️ Q4 swung to a loss, missing EPS estimates, with revenues down 3% year over year on weak auto demand and softer polymer sales. That’s not the kind of momentum you want heading into a new year. Is this a temporary dip or something deeper? See the full breakdown 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-teaser-35381&ADID=SYND_STOCKTWITS_TWEET_2_2876186_TEASER_35381
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 5:11 PM
$NGVT Q4 loss — is the growth story fading? 📉 Ingevity reported a loss of $2.37/share. Adjusted earnings missed Zacks Consensus by 16 cents, with revenue from continuing operations down 3% YoY. Advanced Polymer Tech sales slumped 17%, dragging segment EBITDA down 21% due to weak demand. Discover NGVT's 2026 outlook here 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-body-35379&ADID=SYND_STOCKTWITS_TWEET_2_2876186_BODY_35379
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:45 PM
$NGVT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$2.37 down -615.22% YoY • Reported revenue of $255.1M down -3.15% YoY • Ingevity expects full year 2026 net sales between $1.1B and $1.2B, adjusted EBITDA between $380M and $400M, and adjusted EPS between $4.80 to $5.20, with free cash flow of $225M to $250M.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 13 at 10:37 AM
$NGVT Current Stock Price: $75.29 Contracts to trade: $75.0 NGVT Feb 20 2026 Call Entry: $1.67 Exit: $2.97 ROI: 78% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
macroaxis
macroaxis Feb. 7 at 7:46 PM
$NGVT - Ingevity Options Alert: Put Open Interest Drops to 92.0 – Key Signal for Traders https://www.macroaxis.com/stock-options/NGVT/Ingevity-Corp?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
MarketMandelbrot
MarketMandelbrot Feb. 4 at 9:47 AM
$NGVT engineered materials, packaging and pharma
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 2:22 PM
$NGVT is quietly ripping — up 18.7% in just three months. 🔥 Shares are climbing as asset divestitures and accretive acquisitions sharpen the company’s focus, improve margins, and restore investor confidence. See what’s driving the momentum in NGVT 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-teaser-29015&ADID=SYND_STOCKTWITS_TWEET_2_2817854_TEASER_29015
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 1:22 PM
$NGVT up 18.7% in 3 months — what's driving this rally? 🚀 🔍 Strategic divestiture and acquisitions boost margins 💼 Sale of CTO assets for $110M plus contingent consideration fuels portfolio focus 📈 Growth in construction & infrastructure markets via Ozark Materials buy Discover more about this upward momentum 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-body-28998&ADID=SYND_STOCKTWITS_TWEET_2_2817854_BODY_28998
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 4:18 PM
$NGVT cleans house — $110M cash deal to sharpen the focus ⚡ Ingevity completed a $110M all-cash sale of its North Charleston CTO refinery assets, streamlining operations and doubling down on higher-margin specialties. See what this strategic shift means next 👉 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-teaser-27541&ADID=SYND_STOCKTWITS_TWEET_2_2812650_TEASER_27541
0 · Reply
Latest News on NGVT
Ingevity Corporation (NGVT) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 2:58 PM EST - 13 days ago

Ingevity Corporation (NGVT) Q4 2025 Earnings Call Transcript


Ingevity announces upcoming board transitions

Feb 23, 2026, 4:15 PM EST - 16 days ago

Ingevity announces upcoming board transitions


Ingevity announces key leadership transitions

Dec 8, 2025, 6:30 AM EST - 3 months ago

Ingevity announces key leadership transitions


Ingevity Corporation (NGVT) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 2:16 PM EST - 4 months ago

Ingevity Corporation (NGVT) Q3 2025 Earnings Call Transcript


Ingevity reports third quarter 2025 financial results

Nov 5, 2025, 4:15 PM EST - 4 months ago

Ingevity reports third quarter 2025 financial results


Ingevity Corporation (NGVT) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:30 PM EDT - 7 months ago

Ingevity Corporation (NGVT) Q2 2025 Earnings Call Transcript


Ingevity reports second quarter 2025 financial results

Aug 4, 2025, 4:15 PM EDT - 7 months ago

Ingevity reports second quarter 2025 financial results


Ingevity named one of America's Best Mid-sized Companies by TIME

Jul 22, 2025, 11:00 AM EDT - 8 months ago

Ingevity named one of America's Best Mid-sized Companies by TIME


Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript

May 6, 2025, 12:45 PM EDT - 11 months ago

Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript


Ingevity reports first quarter 2025 financial results

May 5, 2025, 4:15 PM EDT - 11 months ago

Ingevity reports first quarter 2025 financial results


Ingevity Corporation (NGVT) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 12:31 PM EST - 1 year ago

Ingevity Corporation (NGVT) Q4 2024 Earnings Call Transcript


Ingevity elects Kevin Willis to its board of directors

Dec 16, 2024, 4:15 PM EST - 1 year ago

Ingevity elects Kevin Willis to its board of directors


Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:21 PM EDT - 1 year ago

Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript


Ingevity reports third quarter 2024 financial results

Oct 29, 2024, 4:15 PM EDT - 1 year ago

Ingevity reports third quarter 2024 financial results


Ingevity Corporation (NGVT) Q2 2024 Earnings Call Transcript

Aug 2, 2024, 3:26 PM EDT - 1 year ago

Ingevity Corporation (NGVT) Q2 2024 Earnings Call Transcript


Ingevity reports second quarter 2024 financial results

Jul 31, 2024, 4:15 PM EDT - 1 year ago

Ingevity reports second quarter 2024 financial results


IN0V8
IN0V8 Mar. 3 at 6:19 PM
$NGVT 3/2 Buy BMO raises target price to $83 from $70
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 6:11 PM
$NGVT just threw up a red flag ⚠️ Q4 swung to a loss, missing EPS estimates, with revenues down 3% year over year on weak auto demand and softer polymer sales. That’s not the kind of momentum you want heading into a new year. Is this a temporary dip or something deeper? See the full breakdown 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-teaser-35381&ADID=SYND_STOCKTWITS_TWEET_2_2876186_TEASER_35381
0 · Reply
ZacksResearch
ZacksResearch Feb. 26 at 5:11 PM
$NGVT Q4 loss — is the growth story fading? 📉 Ingevity reported a loss of $2.37/share. Adjusted earnings missed Zacks Consensus by 16 cents, with revenue from continuing operations down 3% YoY. Advanced Polymer Tech sales slumped 17%, dragging segment EBITDA down 21% due to weak demand. Discover NGVT's 2026 outlook here 👉 https://www.zacks.com/stock/news/2876186/ngvt-reports-losses-in-q4-missing-estimates-revenues-dip-yy?cid=sm-stocktwits-2-2876186-body-35379&ADID=SYND_STOCKTWITS_TWEET_2_2876186_BODY_35379
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 9:45 PM
$NGVT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$2.37 down -615.22% YoY • Reported revenue of $255.1M down -3.15% YoY • Ingevity expects full year 2026 net sales between $1.1B and $1.2B, adjusted EBITDA between $380M and $400M, and adjusted EPS between $4.80 to $5.20, with free cash flow of $225M to $250M.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 13 at 10:37 AM
$NGVT Current Stock Price: $75.29 Contracts to trade: $75.0 NGVT Feb 20 2026 Call Entry: $1.67 Exit: $2.97 ROI: 78% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
macroaxis
macroaxis Feb. 7 at 7:46 PM
$NGVT - Ingevity Options Alert: Put Open Interest Drops to 92.0 – Key Signal for Traders https://www.macroaxis.com/stock-options/NGVT/Ingevity-Corp?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
MarketMandelbrot
MarketMandelbrot Feb. 4 at 9:47 AM
$NGVT engineered materials, packaging and pharma
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 2:22 PM
$NGVT is quietly ripping — up 18.7% in just three months. 🔥 Shares are climbing as asset divestitures and accretive acquisitions sharpen the company’s focus, improve margins, and restore investor confidence. See what’s driving the momentum in NGVT 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-teaser-29015&ADID=SYND_STOCKTWITS_TWEET_2_2817854_TEASER_29015
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 1:22 PM
$NGVT up 18.7% in 3 months — what's driving this rally? 🚀 🔍 Strategic divestiture and acquisitions boost margins 💼 Sale of CTO assets for $110M plus contingent consideration fuels portfolio focus 📈 Growth in construction & infrastructure markets via Ozark Materials buy Discover more about this upward momentum 👉 https://www.zacks.com/stock/news/2817854/ingevity-rises-more-than-18-in-3-months-whats-driving-the-stock?cid=sm-stocktwits-2-2817854-body-28998&ADID=SYND_STOCKTWITS_TWEET_2_2817854_BODY_28998
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 4:18 PM
$NGVT cleans house — $110M cash deal to sharpen the focus ⚡ Ingevity completed a $110M all-cash sale of its North Charleston CTO refinery assets, streamlining operations and doubling down on higher-margin specialties. See what this strategic shift means next 👉 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-teaser-27541&ADID=SYND_STOCKTWITS_TWEET_2_2812650_TEASER_27541
0 · Reply
ZacksResearch
ZacksResearch Jan. 6 at 3:18 PM
$NGVT reshapes portfolio with $110M divestiture! 🚀 By selling its North Charleston CTO assets, Ingevity sharpens focus on high-margin specialty applications. Shares up 57.9% over the past year — a strategic pivot paying off. See why this matters for investors 👇 https://www.zacks.com/stock/news/2812650/ingevity-completes-divestiture-of-cto-refinery-assets-to-mainstream?cid=sm-stocktwits-2-2812650-body-27539&ADID=SYND_STOCKTWITS_TWEET_2_2812650_BODY_27539
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 4:10 PM
🔥 $NGVT is up 27% in just six months — and this move isn’t random. The rally is being driven by value-creating acquisitions, portfolio optimization, and long-term growth initiatives, all pushing the stock higher over the past half-year. 📈 What’s really fueling the momentum? Full breakdown here 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-teaser-27124&ADID=SYND_STOCKTWITS_TWEET_2_2811302_TEASER_27124
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 3:10 PM
$NGVT's 26.6% share gain over the past six months — what's driving the momentum? 🔥 🚀 Strategic acquisitions boosting margins 📈 Exit from low-margin markets enhancing cash flow 📊 Long-term growth supported by capacity expansions See why NGVT might keep climbing 👉 https://www.zacks.com/stock/news/2811302/whats-behind-ingevitys-27-rally-in-the-past-6-months?cid=sm-stocktwits-2-2811302-body-27123&ADID=SYND_STOCKTWITS_TWEET_2_2811302_BODY_27123
0 · Reply
GenomicsGlow
GenomicsGlow Dec. 27 at 4:19 PM
$NGVT Valuation sensitivity is high because visibility is uneven; customer retention trends will be critical to monitor — measurable traction would outweigh rhetoric. From here, results — not promises — will decide direction.
0 · Reply
Estimize
Estimize Dec. 22 at 12:00 PM
Wall St is expecting 0.69 EPS for $NGVT Q4 [Reporting 02/25 AMC] http://www.estimize.com/intro/ngvt?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 2:35 PM
Wells Fargo has updated their rating for Ingevity ( $NGVT ) to Equal-Weight with a price target of 60.
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 12:57 PM
BMO Capital has updated their rating for Ingevity ( $NGVT ) to Outperform with a price target of 70.
0 · Reply
Estimize
Estimize Nov. 27 at 9:00 PM
Wall St is expecting 0.74 EPS for $NGVT Q4 [Reporting 02/25 AMC] http://www.estimize.com/intro/ngvt?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 3:22 PM
Wells Fargo updates rating for Ingevity ( $NGVT ) to Equal-Weight, target set at 52 → 55.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 10 at 7:10 PM
$NGVT Share Price: $49.53 Contract Selected: Apr 17, 2026 $60 Calls Buy Zone: $1.23 – $1.52 Target Zone: $2.26 – $2.76 Potential Upside: 73% ROI Time to Expiration: 157 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
d_risk
d_risk Nov. 7 at 12:19 AM
$NGVT - Ingevity Corporation Common Stock - 10Q - Updated Risk Factors NGVT flags heightened risks from new U.S.-China tariffs threatening export margins, and warns of increased vulnerability to operational disruptions from labor issues, supply chain dependencies, and post-divestiture changes. #ChemicalsIndustry #Post-DivestitureImpact #LaborDisruptions #SupplyChainRisk #TradeTariffs 🟢 Added 🟠 Removed https://d-risk.ai/NGVT/10-Q/2025-11-06
0 · Reply